COMBIVIR

This brand name is authorized in Austria, Australia, Canada, Cyprus, Germany, Ecuador, Estonia, Spain, Finland, France, Hong Kong, Croatia, Ireland, Japan, Lithuania, Mexico, Netherlands, Poland, Romania, Singapore, Tunisia, Turkey, United Kingdom, United States, South Africa

Active ingredients

The drug COMBIVIR contains a combination of these active pharmaceutical ingredients (APIs):

1
UNII 2T8Q726O95 - LAMIVUDINE
 

Lamivudine is a nucleoside analogue which has activity against human immunodeficiency virus (HIV) and hepatitis B virus (HBV). Its main mode of action is as a chain terminator of viral reverse transcription.

 
Read more about Lamivudine
2
UNII 4B9XT59T7S - ZIDOVUDINE
 

Zidovudine is an antiviral agent which is highly active in vitro against retroviruses including the Human Immunodeficiency Virus (HIV).

 
Read more about Zidovudine

Medication package inserts

Below package inserts are available for further reading:

Document Type Information Source  
 COMBIVIR Film-coated tablet MPI, EU: SmPC European Medicines Agency (EU)

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC Group Classification
J05AR01 Zidovudine and lamivudine J Antiinfectives for systemic use → J05 Antivirals for systemic use → J05A Direct acting antivirals → J05AR Antivirals for treatment of HIV infections, combinations
Discover more medicines within J05AR01

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country Identification scheme Identifier(s)
AU Pharmaceutical Benefits Scheme 10284G
CA Health Products and Food Branch 02239213
DE Bundesinstitut für Arzneimittel und Medizinprodukte 00494433, 00499241, 00728954, 00789074, 00800947, 00970069, 02654970, 08725085, 10227880, 11710696
EC Agencia Nacional de Regulación, Control y Vigilancia Sanitaria 2946-MEE-0817
EE Ravimiamet 1036460
ES Centro de información online de medicamentos de la AEMPS 98058001
FI Lääkealan turvallisuus- ja kehittämiskeskus 101916
FR Base de données publique des médicaments 65521773
GB Medicines & Healthcare Products Regulatory Agency 40280
HK Department of Health Drug Office 63605
JP 医薬品医療機器総合機構 6250100F1032
LT Valstybinė vaistų kontrolės tarnyba 1012168, 1028280, 1055421
MX Comisión Federal para la Protección contra Riesgos Sanitarios 095M98
NL Z-Index G-Standaard, PRK 50059
PL Rejestru Produktów Leczniczych 100088859
RO Agenția Națională a Medicamentului și a Dispozitivelor Medicale W65649001, W65649002
SG Health Sciences Authority 10795P
TN Direction de la Pharmacie et du Médicament 23013031
TR İlaç ve Tıbbi Cihaz Kurumu 8699522096053
US FDA, National Drug Code 49702-202
ZA Health Products Regulatory Authority 32/20.2.8/0705

© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.